Tudor Investment Corporation »

Royalty Pharma shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 71k 28.09
2023-09-30 $5.7M 209k 27.14
2023-06-30 $1.9M 61k 30.74

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Splunk Inc - US Equity
Pioneer Natural Resources Co - US Equity (PXD)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Spdr Dow Jones Industrial Average Etf Trust - US E ETF Option Call Option (DIA)
Exxon Mobil Corp - US Equity (XOM)
Meta Platforms Inc - US Equity (META)
Bristol-Myers Squibb Co - US Equity (BMY)
Texas Instruments Inc - US Equity Option Call Option (TXN)
Enphase Energy Inc - US Equity Option Call Option (ENPH)
United Parcel Service Inc - US Class B Equity Option Call Option (UPS)
Nvidia Corp - US Equity (NVDA)
Bank Of America Corp - US Equity (BAC)
Estee Lauder Cos Inc/The - US Equity (EL)

View all positions for Tudor Investment Corporation

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma